DeepMed Research

Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

African-American Social Support Effectiveness Treatment

Not Applicable

Completed

Conditions: Maternal Perinatal Depression

Interventions: Behavioral: African-American Social Support Effectiveness Treatment-Partners alleviating Perinatal Depression (ASSET-PPD)

First Posted Date: 2023-03-09

Last Posted Date: 2025-03-03

Lead Sponsor: Northwestern University

Target Recruit Count: 100

Registration Number: NCT05762133

Locations: 🇺🇸
Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States

Penn Family Screening for Familial Hypercholesterolemia

Not Applicable

Conditions: Familial Hypercholesterolemia

Interventions: Behavioral: Cascade screening

First Posted Date: 2023-03-02

Last Posted Date: 2024-02-29

Lead Sponsor: Northwestern University

Target Recruit Count: 800

Registration Number: NCT05750667

Locations: 🇺🇸
University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States

Anti-Snoring Appliances and Airway Manipulation in Patients Undergoing Anesthetic Sedation

Not Applicable

Completed

Conditions: Snoring
Airway Obstruction
Sedation Complication

Interventions: Procedure: No anti -snoring device during their procedure.
Device: Anti-snoring device

First Posted Date: 2023-03-01

Last Posted Date: 2023-11-18

Lead Sponsor: Northwestern University

Target Recruit Count: 25

Registration Number: NCT05748626

Locations: 🇺🇸
Northwestern Memorial Hospital and Prentice Women's Hospital, Chicago, Illinois, United States

Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 1

Active, not recruiting

Conditions: Acute Myeloid Leukemia

Interventions: Procedure: Biospecimen Collection
Drug: Tomivosertib

First Posted Date: 2023-02-27

Last Posted Date: 2024-07-19

Lead Sponsor: Northwestern University

Target Recruit Count: 15

Registration Number: NCT05744739

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Fox Chase, Philadelphia, Pennsylvania, United States

Impact of Virtual Reality on Anxiety in Patients Undergoing Interventional Procedures

Not Applicable

Recruiting

Conditions: Anxiety

Interventions: Other: Group 2 Control Group
Other: Group 1 Immersive Virtual Reality (VR)

First Posted Date: 2023-02-27

Last Posted Date: 2024-03-25

Lead Sponsor: Northwestern University

Target Recruit Count: 64

Registration Number: NCT05744336

Locations: 🇺🇸
Anesthesiology Pain Medicine Center, Chicago, Illinois, United States

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Not Applicable

Recruiting

Conditions: Ovary Cancer
Endometrial Cancer
Vulvar Cancer
Cervical Cancer
Vaginal Cancer
Cervix Cancer
Uterine Cancer

Interventions: Behavioral: Fit4Treatment

First Posted Date: 2023-02-24

Last Posted Date: 2025-04-29

Lead Sponsor: Northwestern University

Target Recruit Count: 192

Registration Number: NCT05743517

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Liver Cirrhosis Network Cohort Study

Recruiting

Conditions: Cirrhosis
Cirrhosis, Liver
Cirrhosis Advanced
Cirrhosis, Biliary
Cirrhosis Cryptogenic
Cirrhosis Early
Cirrhosis Due to Hepatitis C
Cirrhosis Due to Hepatitis B
Cirrhosis Infectious
Cirrhosis Alcoholic

First Posted Date: 2023-02-23

Last Posted Date: 2025-05-22

Lead Sponsor: Northwestern University

Target Recruit Count: 1200

Registration Number: NCT05740358

Locations: 🇺🇸
University of California San Diego NAFLD Research Center, La Jolla, California, United States
🇺🇸
Keck Medical Center of USC, Los Angeles, California, United States
🇺🇸
LAC + USC Medical Center, Los Angeles, California, United States

and more 11 locations

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Phase 2

Recruiting

Conditions: Advanced Pancreatic Carcinoma
Metastatic Ovarian Carcinoma
Refractory Lung Adenocarcinoma
Refractory Urothelial Carcinoma
Stage II Pancreatic Cancer AJCC v8
Stage III Ovarian Cancer AJCC v8
Advanced Biliary Tract Carcinoma
Advanced Lung Adenocarcinoma
Advanced Malignant Solid Neoplasm
Advanced Urothelial Carcinoma

Interventions: Procedure: Biospecimen Collection
Procedure: Computed Tomography
Drug: Devimistat
Drug: Fluorouracil
Drug: Gemcitabine Hydrochloride
Drug: Hydroxychloroquine
Procedure: Magnetic Resonance Imaging

First Posted Date: 2023-02-17

Last Posted Date: 2023-03-10

Lead Sponsor: Northwestern University

Target Recruit Count: 94

Registration Number: NCT05733000

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution

Early Phase 1

Not yet recruiting

Conditions: Cutaneous T Cell Lymphoma

Interventions: Combination Product: APR-TD011 (RLF-TD011)

First Posted Date: 2023-02-15

Last Posted Date: 2024-03-12

Lead Sponsor: Northwestern University

Target Recruit Count: 30

Registration Number: NCT05728879

Locations: 🇺🇸
Dermatology CTU, Chicago, Illinois, United States

Sleep and Health Outcomes in Women With Heavy Menses

Not Applicable

Active, not recruiting

Conditions: Menstruation; Heavy

Interventions: Other: Nighttime Feminine Product

First Posted Date: 2023-02-10

Last Posted Date: 2024-03-27

Lead Sponsor: Northwestern University

Target Recruit Count: 25

Registration Number: NCT05722444

Locations: 🇺🇸
Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy